Abstract | BACKGROUND: Tumor hypoxia-induced epithelial-mesenchymal transition (EMT) is critical in promoting cancer metastasis. We recently discovered a novel microtubule inhibitor, MPT0B098, that employs a novel antitumor mechanism. It destabilizes hypoxia-inducible factor (HIF)-1α mRNA by blocking the function of human antigen R. Thus, we proposed that MPT0B098 modulates hypoxia-induced EMT. METHODS: In vitro IC50 values were determined through the methylene blue dye assay. To investigate molecular events, reverse transcriptase-polymerase chain reaction, Western blotting, immunofluorescence staining, and wound healing assay were employed. RESULTS: CONCLUSIONS: Taken together, this study provides a novel insight into the role of MPT0B098 in inhibiting hypoxia-induced EMT, suggesting its potential use for treating head and neck cancers.
|
Authors | I-Ting Tsai, Ching-Chuan Kuo, Jing-Ping Liou, Jang-Yang Chang |
Journal | Journal of biomedical science
(J Biomed Sci)
Vol. 25
Issue 1
Pg. 28
(Mar 28 2018)
ISSN: 1423-0127 [Electronic] England |
PMID | 29592811
(Publication Type: Journal Article)
|
Chemical References |
- HIF1A protein, human
- Hypoxia-Inducible Factor 1, alpha Subunit
- Indoles
- MPT0B098
- Sulfonamides
- Tubulin Modulators
|
Topics |
- Carcinoma, Squamous Cell
(physiopathology)
- Cell Line, Tumor
- Epithelial-Mesenchymal Transition
(drug effects)
- Head and Neck Neoplasms
(physiopathology)
- Humans
- Hypoxia
(physiopathology)
- Hypoxia-Inducible Factor 1, alpha Subunit
(antagonists & inhibitors)
- Indoles
(pharmacology)
- Squamous Cell Carcinoma of Head and Neck
- Sulfonamides
(pharmacology)
- Tubulin Modulators
(pharmacology)
|